Progressive Muscular Dystrophy clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
open to eligible people ages 18-65
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
at UC Irvine UCLA UCSD
Last updated: